TERM ID="NYU_TERM_1" STRING="ACE inhibitors" FREQUENCY=1 START=1030 END=1044 LEMMA="ACE INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="NCCT" FREQUENCY=2 START=722 END=726 LEMMA="NCCT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="NCCT" FREQUENCY=2 START=848 END=852 LEMMA="NCCT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="Recent clinical studies" FREQUENCY=1 START=978 END=1001 LEMMA="RECENT CLINICAL STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Subjects" FREQUENCY=1 START=794 END=802 LEMMA="SUBJECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Urinary calcium loss" FREQUENCY=1 START=509 END=529 LEMMA="URINARY CALCIUM LOSS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Z-scores" FREQUENCY=1 START=932 END=940 LEMMA="Z-SCORE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="calcium excretion" FREQUENCY=1 START=481 END=498 LEMMA="CALCIUM EXCRETION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="cardiovascular disease" FREQUENCY=1 START=142 END=164 LEMMA="CARDIOVASCULAR DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="giving protection" FREQUENCY=1 START=1566 END=1583 LEMMA="GIVING PROTECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="hypertensive subjects" FREQUENCY=1 START=585 END=606 LEMMA="HYPERTENSIVE SUBJECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="negative calcium balance" FREQUENCY=1 START=540 END=564 LEMMA="NEGATIVE CALCIUM BALANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="osteoporosis" FREQUENCY=4 START=192 END=204 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_14" STRING="osteoporosis" FREQUENCY=4 START=404 END=416 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_15" STRING="osteoporosis" FREQUENCY=4 START=780 END=792 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_16" STRING="osteoporosis" FREQUENCY=4 START=1299 END=1311 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_17" STRING="pathogenetic mechanisms" FREQUENCY=2 START=281 END=304 LEMMA="PATHOGENETIC MECHANISM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="pathogenetic mechanisms" FREQUENCY=2 START=441 END=464 LEMMA="PATHOGENETIC MECHANISM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="pathological conditions" FREQUENCY=1 START=96 END=119 LEMMA="PATHOLOGICAL CONDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="positive effect" FREQUENCY=1 START=863 END=878 LEMMA="POSITIVE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="reducing fracture risk" FREQUENCY=1 START=1048 END=1070 LEMMA="REDUCING FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="relative risk" FREQUENCY=1 START=1384 END=1397 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="renal calcium stones" FREQUENCY=1 START=166 END=186 LEMMA="RENAL CALCIUM STONE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="renin-angiotensin system" FREQUENCY=1 START=1129 END=1153 LEMMA="RENIN-ANGIOTENSIN SYSTEM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="risk factor" FREQUENCY=1 START=1283 END=1294 LEMMA="RISK FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="risk factor for osteoporosis" FREQUENCY=1 START=1283 END=1311 LEMMA="OSTEOPOROSI RISK FACTOR" LEMMA_FREQUENCY=1 HEAD_TERM="risk factor" HEAD_LEMMA="RISK FACTOR"
TERM ID="NYU_TERM_27" STRING="spine" FREQUENCY=1 START=955 END=960 LEMMA="SPINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="thiazide- sensitive sodium-chloride cotransporter" FREQUENCY=1 START=671 END=720 LEMMA="THIAZIDE- SENSITIVE SODIUM-CHLORIDE COTRANSPORTER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="total femur" FREQUENCY=1 START=965 END=976 LEMMA="TOTAL FEMUR" LEMMA_FREQUENCY=1
